financetom
Market
financetom
/
Market
/
Can see $60 per barrel as a target for Brent contract, says Probis Securities
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Can see $60 per barrel as a target for Brent contract, says Probis Securities
Dec 28, 2018 3:36 AM

Probis Securities expects Brent contract target to be at $60 per barrel, said Jonathan Barratt, chief information officer of the company.

“I do see few things on the horizon which will probably see supply tightness there. We do have an issue in production capacity around the world and if we have some more disruptions there then I think we will see a squeeze. However, when I look at the prices, when I look at WTI and look at Brent, I think prices can actually move higher from here. I can see $60 per barrel as a target for the Brent contract,” Barratt said.

“There is lot of liquidity in the market due to Christmas trading, I do sit more in the bull camp at the moment. I do think it on quite a way to the downside and I think we are soft low in place for the commodity," added Barratt.

“If everything goes the way we think; the economies will grow, the macro picture stays the same and more importantly if we get good confidence out of the recent rally we are having in the equity markets, then that should flow through recently good demand. So I think the situation in India- it is not a bad time to actually put a hedge in place because I feel that we will get a lot of volatility, but if we do get a dip then it is not a bad time to actually buy," he further mentioned.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Top Midday Gainers
Top Midday Gainers
Nov 3, 2024
02:31 PM EDT, 10/25/2024 (MT Newswires) -- ImmunityBio ( IBRX ) shares soared 66% in recent trading Friday after the company reported Thursday dosing of the first patients in a phase 1 trial that will assess its CAR-NK cellular therapy as a potential treatment for non-Hodgkin's lymphoma. Over 43 million shares traded intraday versus a daily average of roughly 2.9...
Toll Brothers Stock A Buying Opportunity Amid Rising Mortgage Rates: Analyst
Toll Brothers Stock A Buying Opportunity Amid Rising Mortgage Rates: Analyst
Nov 3, 2024
Wedbush analyst Jay McCanless upgraded Toll Brothers, Inc. ( TOL ) to Outperform from Neutral, raising the price forecast to $175 from $148. The analyst indicates that the recent dip in the company’s shares due to rising mortgage rates has created a buying opportunity. With the stock market recently reaching all-time highs, this could positively influence demand. Additionally, the analyst...
Equities Mixed Intraday as Traders Parse Corporate Earnings, Macro Data
Equities Mixed Intraday as Traders Parse Corporate Earnings, Macro Data
Nov 3, 2024
02:31 PM EDT, 10/25/2024 (MT Newswires) -- US benchmark equity indexes were mixed intraday as markets weighed the latest corporate earnings and economic data. The Dow Jones Industrial Average was down 0.6% at 42,127.1 after midday Friday, while the Nasdaq Composite rose 0.5% to 18,515.3. The S&P 500 was little changed at 5,803.1. Among sectors, financials and utilities saw the...
Sector Update: Health Care
Sector Update: Health Care
Nov 3, 2024
03:29 PM EDT, 10/25/2024 (MT Newswires) -- Health care stocks were lower late Friday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each shedding 0.5%. The iShares Biotechnology ETF (IBB) rose 0.2%. In corporate news, Upexi ( UPXI ) shares soared 242% after the company said it was investigating an instance of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved